Summit Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Summit Financial's BMY Position: Q1 2026 in Review
Summit Financial increased its Bristol-Myers Squibb (BMY) stake by 21% in Q1 2026, buying an estimated $881K and bringing the position to 87,272 shares worth $5.29M. The position accounts for 0.07% of the portfolio, ranked #294.
Summit Financial first reported a position in BMY in Q3 2021 and has held it in 19 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Summit Financial held 87,272 shares of Bristol-Myers Squibb worth $5.29M as of Q1 2026.
- Summit Financial bought 15,121 Bristol-Myers Squibb shares in Q1 2026, an estimated $881K.
- Bristol-Myers Squibb made up 0.07% of Summit Financial's portfolio in Q1 2026, its #294 holding.
- Summit Financial first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 19 quarters since.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.